Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Oct. 31, 2021	Oct. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (110,796)	$ (72,156)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation expense	17,242	5,678
Other non-cash expense (income)	(128)	293
Amortization of intangible assets	251	137
Amortization of deferred contract acquisition costs	23,555	12,442
Unrealized foreign exchange (gain) loss	19,752	(13,614)
Changes in assets and liabilities:
Accounts receivable	(17,350)	(18,511)
Prepaid expenses and other current assets	(3,373)	(1,952)
Other long-term assets	(3,120)	(536)
Costs deferred related to contract acquisition	(24,642)	(21,582)
Accounts payable	1,786	318
Accrued expenses and other current liabilities	1,019	1,683
Accrued compensation and benefits	3,812	632
Other long-term liabilities	1,803	688
Deferred revenue	41,469	40,260
Net cash used in operating activities	(48,720)	(66,220)
CASH FLOWS FROM INVESTING ACTIVITIES:
Intangible assets acquisitions, net of cash acquired	0	(933)
Purchases of short-term investments	(100,031)	0
Net cash used in investing activities	(100,031)	(933)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from initial public offering, net of underwriting discounts	654,552	0
Proceeds from the issuance of common stock upon exercise of stock options, including early exercises, net of repurchases	14,574	6,619
Repurchase of common stock	(590)	0
Contributions received from noncontrolling interests	26,450	0
Payments of deferred offering costs	(3,398)	0
Net cash provided by financing activities	691,588	6,619
Impact of foreign exchange on cash and cash equivalents	(973)	485
Net increase (decrease) in cash	541,864	(60,049)
Cash and cash equivalents, beginning of period	282,850	343,327
Cash and cash equivalents, end of period	824,714	283,278
Supplemental disclosure of cash flow information:
Cash paid for income taxes	1,111	1,921
Cash donations	1,000	0
Supplemental disclosure of non-cash investing and financing activities:
Vesting of early exercised stock options	5,425	1,882
Conversion of convertible preferred stock to common stock upon initial public offering	424,904	0
Unpaid deferred offering costs	$ 1,309	$ 0